Accelerate Diagnostics (AXDX) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free AXDX Stock Alerts $0.89 +0.03 (+3.50%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Accelerate Diagnostics Short Interest DataCurrent Short Volume292,600 sharesPrevious Short Volume287,600 sharesChange Vs. Previous Month+1.74%Dollar Volume Sold Short$289,674.00Short Interest Ratio / Days to Cover2.2Last Record DateMarch 31, 2024Outstanding Shares21,660,000 sharesFloat Size13,020,000 sharesShort Percent of Float2.25%Today's Trading Volume18,341 sharesAverage Trading Volume75,061 sharesToday's Volume Vs. Average24% Short Selling Accelerate Diagnostics ? Sign up to receive the latest short interest report for Accelerate Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAXDX Short Interest Over TimeAXDX Days to Cover Over TimeAXDX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Accelerate Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024292,600 shares $289,674.00 +1.7%2.3%2.2 $0.99 3/15/2024287,600 shares $273,220.00 -3.8%2.4%2.4 $0.95 2/29/2024299,000 shares $294,544.90 -13.9%2.5%2.5 $0.99 2/15/2024347,300 shares $413,287.00 -7.2%2.9%3 $1.19 1/31/2024374,200 shares $497,686.00 -16.5%4.2%3.4 $1.33 1/15/2024448,300 shares $1.66 million +9.9%5.8%5.3 $3.70 Get the Latest News and Ratings for AXDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023407,800 shares $1.60 million +3.6%5.3%14.1 $3.92 12/15/2023393,500 shares $1.81 million -10.0%5.1%13.9 $4.61 11/30/2023437,300 shares $1.89 million +11.9%5.8%17.6 $4.32 11/15/2023390,900 shares $2.07 million -2.4%5.2%23.1 $5.29 10/31/2023400,500 shares $2.40 million +11.8%5.4%23 $5.99 10/15/2023358,100 shares $2.11 million +11.5%4.8%17.9 $5.88 9/30/2023321,300 shares $1.85 million -8.9%4.3%13 $5.75 9/15/2023352,600 shares $2.16 million -15.2%4.7%15.3 $6.14 8/31/2023415,800 shares $2.91 million -1.2%9.3%15.6 $7.01 8/15/2023420,900 shares $2.98 million -3.8%9.4%15.1 $7.09 7/31/2023437,400 shares $2.91 million +8.4%14.1%15.9 $6.66 7/15/2023403,500 shares $2.80 million +3.5%13.0%14.6 $6.95 6/30/2023390,000 shares $3.16 million -90.3%12.5%16.3 $8.10 6/15/20234,000,000 shares $3.17 million -7.6%12.9%14.9 $0.79 5/31/20234,330,000 shares $3.03 million +6.7%N/A16.7 $0.70 5/15/20234,060,000 shares $3.25 million -6.0%N/A13.4 $0.80 4/30/20234,320,000 shares $3.81 million -11.1%N/A14 $0.88 4/15/20234,860,000 shares $3.21 million +2.1%N/A16 $0.66 3/31/20234,760,000 shares $3.33 million -6.1%N/A16.2 $0.70 3/15/20235,070,000 shares $2.74 million +7.2%N/A16.6 $0.54 2/28/20234,730,000 shares $2.41 million +5.1%N/A15 $0.51 2/15/20234,500,000 shares $2.70 million +0.5%N/A15.5 $0.60 1/31/20234,480,000 shares $3.11 million +0.5%N/A15.8 $0.69 1/15/20234,460,000 shares $3.21 million -0.7%N/A13.3 $0.72 12/30/20224,490,000 shares $3.17 million +3.7%N/A13.6 $0.71 12/15/20224,330,000 shares $2.94 million -0.2%N/A14.6 $0.68 11/30/20224,340,000 shares $3.77 million +10.7%N/A12.8 $0.87 11/15/20223,920,000 shares $4.78 million -1.3%N/A8.4 $1.22 10/31/20223,970,000 shares $5.04 million -17.6%N/A4.3 $1.27 10/15/20224,820,000 shares $7.42 million -1.8%N/A5.1 $1.54 9/30/20224,910,000 shares $7.46 million -3.0%N/A5.3 $1.52 9/15/20225,060,000 shares $8.30 million -1.8%N/A4.6 $1.64 8/31/20225,150,000 shares $8.39 million -8.9%N/A4.1 $1.63 8/15/20225,650,000 shares $15.14 million +4.4%N/A3.9 $2.68Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide AXDX Short Interest - Frequently Asked Questions What is Accelerate Diagnostics' current short interest? Short interest is the volume of Accelerate Diagnostics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 292,600 shares of AXDX short. 2.25% of Accelerate Diagnostics' shares are currently sold short. Learn More on Accelerate Diagnostics' current short interest. What is a good short interest ratio for Accelerate Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXDX shares currently have a short interest ratio of 2.0. Learn More on Accelerate Diagnostics's short interest ratio. Which institutional investors are shorting Accelerate Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Accelerate Diagnostics: Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Accelerate Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.25% of Accelerate Diagnostics' floating shares are currently sold short. Is Accelerate Diagnostics' short interest increasing or decreasing? Accelerate Diagnostics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 292,600 shares, an increase of 1.7% from the previous total of 287,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Accelerate Diagnostics' float size? Accelerate Diagnostics currently has issued a total of 21,660,000 shares. Some of Accelerate Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Accelerate Diagnostics currently has a public float of 13,020,000 shares. How does Accelerate Diagnostics' short interest compare to its competitors? 2.25% of Accelerate Diagnostics' shares are currently sold short. Here is how the short interest of companies compare to Accelerate Diagnostics: Talis Biomedical Co. (0.80%), Telesis Bio, Inc. (1.14%), Singular Genomics Systems, Inc. (1.73%), Rapid Micro Biosystems, Inc. (0.31%), Akili, Inc. (0.31%), Minerva Neurosciences, Inc. (0.74%), Agape ATP Co. (0.03%), STRATA Skin Sciences, Inc. (1.17%), Talphera, Inc. (0.70%), ATI Physical Therapy, Inc. (0.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Accelerate Diagnostics stock? Short selling AXDX is an investing strategy that aims to generate trading profit from Accelerate Diagnostics as its price is falling. AXDX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Accelerate Diagnostics? A short squeeze for Accelerate Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXDX, which in turn drives the price of the stock up even further. How often is Accelerate Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXDX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Talis Biomedical Short Interest Data Telesis Bio Short Interest Data Singular Genomics Systems Short Interest Data Rapid Micro Biosystems Short Interest Data Akili Short Interest Data Minerva Neurosciences Short Interest Data Agape ATP Short Interest Data STRATA Skin Sciences Short Interest Data Talphera Short Interest Data ATI Physical Therapy Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXDX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative